| Application no. and date | 12795842.9 (espacenet) (Federated) (European Patent Register), 20121130 | | Patent/reg. no. and date | DK/EP 2785349, 20191016 | | Publication date | 20141008 | | Priority no. and date | US 201161564975 P, 20111130 | | EP pub. no. and date |
EP 2785349 20141008 | | Effective date | | | Applicant/owner | Astrazeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | 1640750 | | Inventor | DAVIES, Barry, Robert, AstraZeneca R&D Alderley
Alderley Park
Macclesfield
Cheshire SK10 4TG, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/277 (2006.01) , A61K 31/4166 (2006.01) , A61K 31/5025 (2006.01) , A61K 31/519 (2006.01) , A61K 31/58 (2006.01) , A61P 13/08 (2006.01) , A61P 35/00 (2006.01) | | Title | KOMBINATIONSBEHANDLING AF CANCER | | Int. application no. | GB2012052969 | | Int. publication no. | WO2013079964 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
